Pharming Announces U.S. FDA Approval of Joenja as the First and Only Treatment Indicated for APDS By Investing.com

Pharming (PHAR) Announces US FDA Approval of Joenja® (leniolisib) as the First and Only Treatment Indicated for APDS (Updated – March 24, 2023 2:33 p.m. EDT) Pharming Group S.A. (“Agriculture” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the US Food and Drug Administration (FDA) has approved Joenja® (leniolisib) for the treatment of activated…

Read More
Bayer and Orion’s Nubeqa Obtain Approval in China for Widespread Use in Prostate Cancer

Bayer and Orion’s Nubeqa Obtain Approval in China for Widespread Use in Prostate Cancer

JFsPic/iStock Editorial via Getty Images China’s National Medical Products Administration (NMPA) has approved Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) and Orion Corporation’s oral drug Nubeqa, in combination with docetaxel, to treat patients with prostate cancer. hormone-sensitive metastatic prostate (mHSPC). The German conglomerate noted that Nubeqa (darolutamide) is already approved in China to treat patients with non-metastatic castration-resistant prostate…

Read More
Sanofi and Regeneron Dupixent win EU approval to treat eczema in children over 6 months

Sanofi and Regeneron Dupixent win EU approval to treat eczema in children over 6 months

artJazz The European Commission (EC) has approved Sanofi (NASDAQ: SNY) and Regeneron Pharmaceuticals (NASDAQ: REGN) Dupixent for the treatment of severe atopic dermatitis (eczema) in children aged six months to five years who are eligible for systemic therapy. The French pharmaceutical giant said that with approval Dupixent (dupilumab) is the first and only targeted drug…

Read More
Central Bank of Indonesia governor wins approval of new term by parliamentary body By Reuters

Central Bank of Indonesia governor wins approval of new term by parliamentary body By Reuters

© Reuters. FILE PHOTO: A woman walks behind a logo of Indonesia’s central bank, Bank Indonesia, in Jakarta November 17, 2016. REUTERS/Beawiharta By Stefanno Sulaiman JAKARTA (Reuters) – Indonesia’s central bank governor Perry Warjiyo won the approval of a key parliamentary body on Monday for his reappointment to a second term, after pledging to maintain…

Read More